(IN BRIEF) Novartis, through its wholly owned subsidiary Torino Merger Sub Inc., has launched a tender offer to acquire all outstanding shares of Tourmaline Bio, Inc. at USD 48 per share in cash. The offer commenced September 29, 2025, and … Read the full press release
Posted in Business, Healthcare, Investment, Pharma & Biotech, Switzerland
Tagged acquisition, biopharma acquisition, Computershare Trust Company, Hart-Scott-Rodino Act, Innisfree M&A, M&A, Merger Agreement, Novartis, Novartis Commences Tender Offer to Acquire Tourmaline Bio for USD 48 Per Share, Novartis Moves Forward with Acquisition of Tourmaline Bio Through Tender Offer, Novartis Pursues Strategic Acquisition of Tourmaline Bio with USD 48 Per Share Tender, Schedule 14D-9, Schedule TO, SEC filing, shareholder offer, tender offer, Torino Merger Sub, Tourmaline Bio, USD 48 per share
(IN BRIEF) EQT has launched a USD 320 million tender offer through its BPEA EQT Mid-Market Growth Partnership to acquire and privatize CareNet, a leading Japanese digital healthcare platform listed on the Tokyo Stock Exchange. Offering JPY 1,130 per share, … Read the full press release
Posted in Business, Healthcare, Industrial, Investment, Sweden, Technology
Tagged 130 per share, Asia Pacific investment, BPEA EQT Mid-Market Growth Partnership, CareNet, Compass, digital healthcare, EQT, Healthcare Innovation, HRBrain, Indium, Japan healthcare technology, JPY 1, medical education platform, pharmaceutical marketing, Privatization, Takanobu Hara, tender offer, Teruyuki Asaoka, Tokyo Stock Exchange, WSO2
(IN BRIEF) Sanofi has completed its purchase of Blueprint Medicines, acquiring the approved systemic mastocytosis therapy Ayvakit/Ayvakyt (avapritinib), along with two pipeline candidates: elenestinib (a KIT D816V inhibitor in Phase 2/3 HARBOR, NCT04910685) and BLU‑808 (a wild‑type KIT inhibitor). The $129.00‑per‑share … Read the full press release
Posted in Business, Financial, France, Government, Healthcare, Industrial, Investment, Management, Marketing, News, Pharma & Biotech, Science, Security & Safety, Technology
Tagged $129.00 per share, avapritinib, Ayvakit, Ayvakyt, Blueprint Medicines, BLU‑808, contingent rights, elenestinib, GIST, HARBOR, KIT inhibitor, MERGER, NASDAQ delisting, NCT04910685, partnership, PDGFRA D842V, Sanofi, SM, sustainability, systemic mastocytosis, tender offer
(IN BRIEF) CompuGroup Medical’s governing bodies have endorsed CVC Capital Partners’ voluntary public tender offer, recommending that shareholders accept the proposed price of €22.00 per share. Following a thorough evaluation of the offer, including fairness opinions from Deutsche Bank and … Read the full press release
Posted in Business, Germany, Healthcare, Management
Tagged Administrative Board, AI technology, cloud-based software, CompuGroup Medical, CVC Capital Partners, Daniela Hommel, delisting offer, Deutsche Bank, fairness opinions, Frank Gotthardt, Gotthardt family, growth strategy, J.P. Morgan, Managing Directors, minimum acceptance threshold, Philipp von Ilberg, Prof. Dr. Daniel Gotthardt, regulatory conditions, share acceptance period, Supervisory Board, tender offer, voluntary public tender offer
(IN BRIEF) Ørsted A/S has finalized its invitation to holders of its EUR 500,000,000 2.25% green hybrid capital securities due in 3017 to tender their securities for purchase by Ørsted for cash. With EUR 249,544,000 in aggregate principal amount of … Read the full press release
Posted in Business, Denmark, Economy, Energy, Gas & Oil, Environment, Financial, Industrial, Investment, Management, News
Tagged Financial, Hybrid Capital Securities, investment, sustainability, tender offer, Ørsted
(PRESS RELEASE) PARIS, 9-Dec-2021 — /EuropaWire/ — Vivendi (EPA: VIV), a French media conglomerate, has announced it will acquire Amber Capital’s stake in Lagardère, an international group with operations in over 40 countries, in the coming days and file a … Read the full press release
Posted in Business, France, Investment, Media, News
Tagged acquisition, Amber Capital, French Market Authority, Lagardère, public tender, share capital, shares, tender offer, Vivendi
(PRESS RELEASE) LUXEMBOURG, 14-Oct-2020 — /EuropaWire/ — ArcelorMittal SA (AMS: MT), the world’s leading steel and mining company, has announced the results of its offer to purchase for cash any and all of its 6.125% Notes due 2025. On October … Read the full press release
(PRESS RELEASE) PARIS, 28-Aug-2020 — /EuropaWire/ — French multinational pharmaceutical company Sanofi announces its intention to commence a tender offer (the “Offer”) to acquire all of the outstanding shares of common stock of Principia Biopharma Inc. for $100 per share … Read the full press release
Posted in France, Healthcare, News, Pharma & Biotech
Tagged acquisition, biopharmaceutical, BofA Securities, BTK inhibitor, Centerview Partners LLC, Cooley LLP, Evercore, Gotshal & Manges LLP, Healthcare, immune thrombocytopenia, immune-mediated diseases, ITP, Kortex Acquisition Corp., MERGER, Merger Agreement, outstanding shares, Principia Biopharma Inc., rilzabrutinib, Sanofi, stock, Tailored Covalency®, tender offer, Weil
LONDON, 21-Dec-2016 — /EuropaWire/ — CNH Industrial N.V. (NYSE: CNHI /MI: CNHI) (“CNH Industrial”) hereby announces the final results of the cash tender offer (the “Tender Offer”) commenced by its wholly owned subsidiary Case New Holland Industrial Inc. (the “Company”) for … Read the full press release
Posted in Agriculture, Financial, Industrial, Investment, United Kingdom
Conceptus imminently to become a wholly-owned Bayer subsidiary Leverkusen, 5-6-2013 — /europawire.eu/ — The Bayer Group has successfully completed its tender offer for the outstanding shares of Conceptus, Inc., Mountain View, California (NASDAQ:CPTS). As of the expiration of the offer period … Read the full press release
EuropaWire (EW) is the first truly pan-European and leading press release distribution and newswire service for Europe and the European Union working towards consolidating Europe’s voice on the global newswire and media scene. The newswire service comes with advanced submission forms, flexible pricing and PR budgeting, granular targeting, nearly uncapped reach across countries, markets, verticals, industries, audiences, languages, etc., translation and localisation for greater local PR impact, in-depth distribution reporting, metrics and insights including measured PR reach, reads, engagements, impact, etc., no cap on words, images and multimedia to go along with your release, among others. Your press releases will be seen among the releases of Europe’s biggest and most prominent companies, brands and institutions. Here you can learn more about EuropaWire’s mission, achievements, services, etc.
HOW TO GET STARTED?